Loading…
Wednesday, June 29 • 2:00pm - 3:15pm
#334: Risky Business: Latest Trends, Strategies, and Tools for Predicting Success and Monitoring Risk During Clinical Trial Operations

Sign up or log in to save this to your schedule, view media, leave feedback and see who's attending!

Limited Capacity seats available

Component Type: Symposium
Level: Intermediate
CE: CME 1.25; IACET 1.25; RN 1.25

There is no crystal ball for forecasting definitively whether an investigator or site will fulfill the promised number of participants for a clinical trial, finish on time and within budget, or provide high quality data. There are, however, some new ways of developing key performance metrics that can help organizations hone in on the right investigators for a particular study early on in the trial planning process. This interactive session features a panel of leaders in pharmaceutical industry analytics who will describe the current data environment for clinical trial operations, lay out innovative metrics and related data sources, and help the audience map out a plan for implementing performance assessments that use all the data available to them. This frank exchange of ideas and practical experiences to weigh the trade-offs among various metrics and processes will have a particular emphasis on risk-based monitoring trends.

Learning Objectives

Explain how organizations are using e-data sources to support risk-based monitoring (RBM) approaches; Compare RBM industry trends to your organization’s experience; Identify potential data sources and/or innovative metrics to predict and measure site performance; Formulate a plan for implementing performance assessments.

Chair

Angelique Hopkins, MPH

Speaker

RBM Industry Trends: How the Landscape Has Changed Between 2013-15
Linda B. Sullivan, MBA

Metrics, Not Magic: Predicting Risk of Site Failure
Lucas Glass, MS



Chair
avatar for Angelique Hopkins

Angelique Hopkins

Associate Director Clinical Trial Analytics, Bristol-Myers Squibb Company
Angelique Hopkins is an Associate Director of Clinical Trial Analytics in Business Insights & Analytics at Bristol-Myers Squibb supporting clinical trial planning. She has a B.S. in Biology from The College of New Jersey, a M.P.H from Drexel University and is completing her doctoral... Read More →

Speakers
avatar for Lucas Glass

Lucas Glass

Head of Machine Learning Research, QuintilesIMS
Lucas Glass manages global data science and machine learning research for clinical operations within QuintilesIMS . Prior to QuintilesIMS, Lucas worked as a statistician within the United States Attorney’s Office Healthcare Fraud Department where he worked on data mining and causation... Read More →
avatar for Linda Sullivan

Linda Sullivan

Senior Advisor, Metrics and Performance Management, WCG, United States
Ms. Sullivan serves as the Senior Advisor, Metrics & Performance Management at WCG. She is the Co-Founder & former Executive Director of the Metrics Champion Consortium (MCC), an industry association dedicated to leading the drug-development enterprise in the adoption and utilization... Read More →


Wednesday June 29, 2016 2:00pm - 3:15pm EDT
113B Pennsylvania Convention Center 1101 Arch Street, Philadelphia, PA 19107 USA